Medical Bulletin 01/August/2026

Researchers from the University of Galway analyzed data from 793 participants in the US-based Framingham Heart Study, none of whom had dementia at the beginning of the research. The participants were about 39 years old when their blood vitamin D levels were measured.

Around 16 years later, approximately 430 participants underwent positron emission tomography (PET) brain scans to assess the accumulation of tau and amyloid beta proteins, two key biomarkers associated with Alzheimer's disease.

The researchers found that participants with higher vitamin D levels in midlife had lower levels of tau protein deposits in the brain during later-life scans. However, no significant association was observed between vitamin D levels and amyloid beta accumulation.

Tau proteins are known to form harmful tangles inside brain cells and are strongly linked to the progression of Alzheimer's disease. Lower tau accumulation may therefore indicate a reduced risk of future neurodegeneration.

Because the study was observational, the researchers emphasized that the findings show only an association and cannot confirm that vitamin D directly prevents Alzheimer's-related brain changes.

The team noted that previous studies mainly examined adults aged 70 years and older, whereas this research focused on younger, cognitively healthy adults, offering a greater opportunity to study preventive factors before disease develops.

The researchers believe future clinical trials are needed to determine whether long-term vitamin D supplementation during midlife can reduce tau accumulation or help prevent dementia. They suggest that earlier intervention may provide a better opportunity for protecting long-term brain health.

REFERENCE: Martin David Mulligan, Qiong Yang, et al.; Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adults; Neurology Open Access; 2026; https://doi.org/10.1212/WN9.0000000000000057

New Study Links High Fructose Intake to Faster Ovarian Cancer Progression

Researchers have discovered an unexpected way that fructose, a common dietary sugar, may promote the spread of ovarian cancer, particularly after chemotherapy. The study, published in Nature Aging, suggests that fructose acts as a signaling molecule released by chemotherapy-surviving cancer cells, helping neighboring tumor cells become more invasive.

Scientists at The Wistar Institute focused on ovarian cancer, which is commonly treated with platinum-based chemotherapy. Although many patients initially respond well, the disease frequently returns and spreads within the abdominal cavity, where metastasis causes about 90% of ovarian cancer deaths.

The researchers found that some cancer cells survive chemotherapy without continuing to divide. Instead, these cells remain biologically active and release signaling molecules that influence nearby cancer cells.

In laboratory and preclinical experiments, the team collected substances released by chemotherapy-resistant cells and showed that these molecules alone—not the surviving cells themselves—were enough to significantly increase cancer spread.

Further analysis identified fructose as a key signaling molecule responsible for this effect. Surprisingly, the researchers also found that high dietary fructose intake, similar to levels found in sugary drinks, could promote cancer cell spread even without chemotherapy.

The team then investigated how fructose increases metastasis. They discovered that fructose suppresses cholesterol production inside neighboring cancer cells. Because cholesterol helps cells remain attached to one another, reduced cholesterol weakens this cellular "glue," allowing cancer cells to detach more easily and spread.

The researchers also observed that statins, widely used cholesterol-lowering medications, produced a similar reduction in cell adhesion. While the findings raise questions about whether statins could influence chemotherapy responses, the researchers stress that patients should not stop taking prescribed statins, as the results have not yet been confirmed in clinical studies.

Although the research focused on ovarian cancer, the scientists believe the same mechanism could potentially apply to other abdominal cancers, including pancreatic, liver, and colorectal cancers.

REFERENCE: Cole, A. R., et al. (2026). The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming. Nature Aging. DOI: 10.1038/s43587-026-01172-5.

Gut-Brain Connection May Determine Which Experiences Become Lasting Memories: Study

Signals from the stomach may help the brain decide which food-related experiences are worth remembering, according to a new study published in Nature Communications. Researchers found that nutrient signals traveling from the gut to the brain through the vagus nerve play an important role in memory formation, while long-term consumption of unhealthy diets may weaken this communication.

Scientists at the USC Dornsife College of Letters, Arts and Sciences studied how the vagus nerve, which connects the digestive system and the brain, influences learning and memory.

In experiments involving rats, eating nutrient-rich foods increased the release of acetylcholine, a neurotransmitter essential for learning and memory, in neurons connected to the hippocampus, the brain's memory center. However, when communication through the vagus nerve was disrupted, acetylcholine levels no longer increased after eating, and the animals performed worse on tasks requiring them to remember where food had previously been found.

The researchers also discovered that the brain responded to the nutritional value of food rather than simply its sweet taste. Rats consuming foods rich in sugar or fat showed strong activation of memory-related brain pathways, whereas animals given sweet-tasting, low-calorie or non-caloric liquids did not produce the same response.

However, repeated exposure to high-fat and high-sugar diets appeared to have the opposite long-term effect. Rats fed unhealthy diets early in life later showed weaker communication between the gut and the hippocampus, even after returning to a healthier diet. They also demonstrated poorer memory performance when locating food.

The findings may help explain why obesity, poor diet, and metabolic diseases have been linked to cognitive decline. Because reduced acetylcholine signaling is also one of the earliest changes seen in Alzheimer's disease, the researchers suggest that therapies targeting the gut-brain connection, including vagus nerve stimulation, may one day help support memory.

REFERENCE: Logan Tierno Lauer, Anna M. R. Hayes, et al.; The vagus nerve promotes memory in rats via nutrient-induced septo-hippocampal acetylcholine signaling. Nature Communications, 2026; 17 (1) DOI: 10.1038/s41467-026-73896-2